Unless the can claim coverage under another code - coverage is lost. All those years of effort and waiting down the drain.
The will likely put the KP contract at risk. If KP can’t claim the costs they will not order the tests.
This is a company killer IMO. They have a large amount of money in the bank, but if Novartis don’t consider the rest medically necessary- game over.
- Forums
- ASX - By Stock
- Ann: Trading Halt
Unless the can claim coverage under another code - coverage is...
-
- There are more pages in this discussion • 21 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PEB (ASX) to my watchlist
|
|||||
Last
8.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $66.57M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 122 | 8.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
10.0¢ | 100000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 122 | 0.083 |
1 | 37250 | 0.080 |
1 | 300000 | 0.069 |
1 | 100000 | 0.065 |
1 | 10000 | 0.050 |
Price($) | Vol. | No. |
---|---|---|
0.100 | 100000 | 1 |
0.000 | 0 | 0 |
0.000 | 0 | 0 |
0.000 | 0 | 0 |
0.000 | 0 | 0 |
Last trade - 16.12pm 28/08/2024 (20 minute delay) ? |
Featured News
PEB (ASX) Chart |
Day chart unavailable
The Watchlist
HAR
HARANGA RESOURCES LIMITED.
Peter Batten, MD
Peter Batten
MD
Previous Video
Next Video
SPONSORED BY The Market Online